These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 16184376)

  • 1. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats.
    Beardsley PM; Howard JL; Shelton KL; Carroll FI
    Psychopharmacology (Berl); 2005 Nov; 183(1):118-26. PubMed ID: 16184376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats.
    Beardsley PM; Pollard GT; Howard JL; Carroll FI
    Psychopharmacology (Berl); 2010 Jun; 210(2):189-98. PubMed ID: 20372878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.
    Carroll I; Thomas JB; Dykstra LA; Granger AL; Allen RM; Howard JL; Pollard GT; Aceto MD; Harris LS
    Eur J Pharmacol; 2004 Oct; 501(1-3):111-9. PubMed ID: 15464069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
    Schank JR; Goldstein AL; Rowe KE; King CE; Marusich JA; Wiley JL; Carroll FI; Thorsell A; Heilig M
    Addict Biol; 2012 May; 17(3):634-47. PubMed ID: 22515275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.
    Thomas JB; Atkinson RN; Vinson NA; Catanzaro JL; Perretta CL; Fix SE; Mascarella SW; Rothman RB; Xu H; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 2003 Jul; 46(14):3127-37. PubMed ID: 12825951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats.
    Sedki F; Eigenmann K; Gelinas J; Schouela N; Courchesne S; Shalev U
    Addict Biol; 2015 May; 20(3):423-32. PubMed ID: 24725195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
    Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats.
    Xi ZX; Gilbert J; Campos AC; Kline N; Ashby CR; Hagan JJ; Heidbreder CA; Gardner EL
    Psychopharmacology (Berl); 2004 Oct; 176(1):57-65. PubMed ID: 15083257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model.
    Carroll FI; Harris LS; Aceto MD
    Eur J Pharmacol; 2005 Nov; 524(1-3):89-94. PubMed ID: 16236279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats.
    Page S; Mavrikaki MM; Lintz T; Puttick D; Roberts E; Rosen H; Carroll FI; Carlezon WA; Chartoff EH
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):735-745. PubMed ID: 31613314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats.
    Funk D; Coen K; Lê AD
    Brain Behav; 2014 May; 4(3):356-67. PubMed ID: 24944865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
    Cai TB; Zou Z; Thomas JB; Brieaddy L; Navarro HA; Carroll FI
    J Med Chem; 2008 Mar; 51(6):1849-60. PubMed ID: 18307295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats.
    Deehan GA; McKinzie DL; Carroll FI; McBride WJ; Rodd ZA
    Pharmacol Biochem Behav; 2012 Jun; 101(4):581-7. PubMed ID: 22429993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats.
    McReynolds JR; Doncheck EM; Vranjkovic O; Ganzman GS; Baker DA; Hillard CJ; Mantsch JR
    Psychopharmacology (Berl); 2016 Jan; 233(1):99-109. PubMed ID: 26455361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in Rats.
    Owens SM; Pollard GT; Howard JL; Fennell TR; Snyder RW; Carroll FI
    ACS Chem Neurosci; 2016 Dec; 7(12):1737-1745. PubMed ID: 27700049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.
    Funk D; Coen K; Tamadon S; Lê AD
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):724-734. PubMed ID: 31556948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats.
    Wang J; Fang Q; Liu Z; Lu L
    Psychopharmacology (Berl); 2006 Mar; 185(1):19-28. PubMed ID: 16374599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.
    Shaham Y; Erb S; Leung S; Buczek Y; Stewart J
    Psychopharmacology (Berl); 1998 May; 137(2):184-90. PubMed ID: 9630005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.